MENU
ABUS
AS OF
Dec 24 closing price
Price
$4.79
Change
+$0.11 (+2.35%)
Capitalization
921.23M
63 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ABUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arbutus Biopharma (ABUS) Ownership - Who owns Arbutus Biopharma?

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
921.23M
P/E Ratio
N/A
Total Cash
93.7M
Projected Growth
N/A
Total Debt
922K
Revenue
14.61M
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash/Share
0.49
Total Debt/Equity
N/A
Revenue/Share
0.08 USD as % of share price

Fundamentals

ABUS
Capitalization
921M
P/E Ratio
N/A
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash
93.7M
Total Cash/Share
0.49
Total Debt
922K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.08%
Revenue
14.6M
ROE
N/A
Book Value
77.4M
P/B Ratio
11.90
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.42B
Current Ratio
18.80
Current Revenue Per Employee
12022.73
Dividends Per Share - Security
N/A
EBITDA
-41.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
-1.77
Revenue To Assets
-35.50
Shares Held By Institutions
718M
Shares Outstanding - Current
192M
Total Liabilities
20.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
46.483
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ABUS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABUS showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ABUS
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com